Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Announces Participation in Upcoming Canaccord Genuity Virtual Conference

Golden Leaf Holdings (CSE: GLH) (OTCQB: GLDFF), operating as Chalice Brands and a premier, consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, will be participating in Canaccord Genuity’s 2021 Virtual Cannabis Conference. The one-day conference is scheduled for today, May 11, 2021. GLDFF CEO and president Jeff Yapp, along with executive chairman John Varghese will present during the conference; their live presentation will begin at 3:30 p.m EDT. Canaccord Genuity’s annual global cannabis conference is an investor-focused event designed to create a premier opportunity for global leading players in the cannabis industry to gather together and connect.

To register for the event, visit https://cnw.fm/Hyn8a

To view the full press release, visit https://cnw.fm/rDWzV

About Golden Leaf Holdings Ltd.

Golden Leaf Holdings is a premiere, consumer-driven cannabis company specializing in production, processing, wholesale, distribution and retail, with seven dispensaries in Portland, Oregon. The company is committed to developing a dynamic portfolio built around the recognized brands of Chalice Farms, with a focus on health and wellness. Markets served include Oregon, California, Nevada and Washington. For more information about this company, visit www.GoldenLeafHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to GLDFF are available in the company’s newsroom at https://cnw.fm/GLDFF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Maryland Court Declares Cannabis Smell Insufficient as Justification for Police Stops, Searches

An appeals court in Maryland has ruled that law enforcement officers aren’t allowed to stop individuals based on the smell of cannabis alone. The decision, which was announced last week, stated that the smell of cannabis didn’t give officers egal justification to stop and examine someone. It noted that officers needed “reasonable suspicion” that there was a crime being carried out before they could detain an individual.

The court ruled that cannabis smell would no longer be used as a basis to stop or detain someone because cannabis in small amounts has been decriminalized in the state. University of Baltimore Law School professor David Jaros stated that the rulings demonstrated that the courts were considering the decriminalization laws in their decision making. The state enacted its decriminalization laws a few years ago, in 2014.

This ruling also limits the small transgressions that officers use to justify their actions. It arose from a Prince George County case where a law enforcement officer had responded to information about a group of males who were meeting at an apartment complex. The facts in the court opinion indicated that the police officer smelled an odor of cannabis when he arrived, which led to his questioning the group; eventually both he and another officer patted down some of the individuals. He recovered a handgun from one of the boys who was a juvenile.

The public defender, who was the accused’s counsel, noted that officers often used the smell of cannabis as an excuse to justify examining individuals further, adding that it was commonly used on individuals of color as a justification for further examination. The state’s representative from the Attorney General’s office refused to give a comment on the case, in addition to not revealing if they planned to appeal the court’s ruling.

While medical cannabis is legal in the state of Maryland, efforts to legalize recreational marijuana stalled in the state’s legislature. It should be noted though, that the court’s decision does not prevent officers of the law from searching vehicles if they smell cannabis, as there’s a different set of rules for vehicles.

Wicomico County sheriff Mike Lewis stated that, while he agreed with the decision in this case, he was concerned that future rulings may limit the ability of officers of the law to search cars if they smelled cannabis. He noted that this was a tool that law enforcement use to find illegal and large quantities of marijuana.

Fortunately, people across the country can still access THC-free products made by entities such as The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER). Such products contain a range of other popular compounds, such as CBD and terpenes found in the hemp plant. Using these legal products can keep individuals on the safe side of the law in Maryland and elsewhere.

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Collaborates to Deliver Innovative Plant-Based Medical Solutions in New Zealand

RYAH Group’s (CSE: RYAH) wholly owned subsidiary, RYAH Medtech Inc., a medical device, data and technology company, today announced its entry into a definitive wholesale supply and distribution agreement with Medical Kiwi Ltd, a leader in research and development, manufacturing, cultivation and distribution of medical cannabis and medical devices. The newly formed agreement, executed on April 5, 2021, implies distribution of the RYAH Smart Inhaler and cloud-based data analytics platform in New Zealand. “Our new partnership with Medical Kiwi Ltd in New Zealand further expands our global clinical and distribution network for plant-based medicine and digital patient care,” said Gregory Wagner, CEO of RYAH Group Inc. and RYAH Medtech Inc. “In December 2019, the New Zealand Government passed legislation to improve access to medical cannabis products. Our new relationship with Medical Kiwi presents an opportunity for both parties to drive innovation and to deliver cutting-edge plant-based medical solutions in New Zealand.”

To view the full press release, visit https://cnw.fm/hz7kU

About RYAH Group Inc.

RYAH is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and licensed processors (”LPs”) to monitor and manage formulation effects on patients and demographics. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation lifecycle. For more information about the company, please visit www.RYAHGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://cnw.fm/RYAH

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Releases Q1 2021 Report, Business Updates

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients, reported its first-quarter 2021 financial and operating results. Highlights from the report include the appointment of Dr. Mathias Schuetz to vice president and Dr. Trish Choudhary to vice president, research & development; the closing of its public offering, comprised of 17.4 million common shares sold for $1.65 per share; and the completion of its first commercial-scale fermentation run of its first cannabinoid — cannabigerol (“CBG”) — for market. In addition, the reported noted that Willow Biosciences had advanced its work on its proprietary yeast strain producing tetrahydrocannabinol (“THC”) and has plans to commercially launch a product in the Canadian market. In addition, the company also named a new member to its board of directors: Barbara Munroe. “The first quarter represented another significant move forward for us, as we completed our first commercial scale fermentation run and strengthened our balance sheet for success,” said Willow Biosciences president and CEO Trevor Peters in the press report. “We are entering the next phase for the company, which is creating new markets for our ultra-pure, sustainably made, cannabinoids, and our world class team has allowed us to be at the forefront of the industry. As the industry continues to move towards increased regulation from a health and safety perspective, there is a need now more than ever for Willow’s consistent and safe manufacturing process. We are excited to continue to deliver value for all Willow stakeholders.”

To view the full press release, visit https://cnw.fm/wCihF

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Vancouver, British Columbia, that develops and produces high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. Willow’s manufacturing process creates a consistent, scalable and sustainable product that benefits industry and consumers. Willow’s team has a proven track record of developing and commercializing bio-based manufacturing processes and products for both the consumer and pharmaceutical industries. For more information about the company, visit www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW — New York to Generate More Than $240 Million Annually in Cannabis Sales by 2024

According to a recent budget analysis by New York’s comptroller, projections show that the state will be raking in more than $240 million in annual cannabis revenue in the near future. For the first year of marijuana sales, New York is expected to bring in only $20 million in fee and tax collections. This is part of a $26.7 billion evaluation in new revenues that the state is expected to bring in for its 2021/2022 fiscal year, under a budget that the state legislature approved in April.

The analysis notes that the new revenue sources with the most substantial fiscal impacts are the corporate and personal income tax increases, despite increased receipts occurring from the legalization of sports betting and cannabis. It adds that while the former revenue sources are only short-term, marijuana represents a long-term revenue opportunity.

The report by Thomas DiNapoli, the state’s comptroller, also highlights that the cannabis tax revenue is projected to grow from the $20 million in tax revenue generated for the 2021–2022 fiscal year to over $110 million for the 2022–2023 fiscal year, just over $150 million for the 2023/2024 fiscal year and more than $240 million for the 2024–2025 fiscal year.

The analysis states that the continuous economic recovery of the state has improved predictions, with tax collections outdoing expectations. It adds that New York will benefit from online sports betting, the legalization of recreational cannabis, and new revenues from increases in tax and federal aid, which brings the total down to about $26.7 billion for the state’s 2021–2022 fiscal year.

New York Gov. Andrew Cuomo had, in March, signed a bill to legalize adult-use marijuana. As stipulated in the bill, retail shops will be launched after the first retail recreational sales begin. In addition, once home cultivation becomes legal, the bill notes that people could store up to five pounds of cannabis at home.

The bill also stipulated that the taxes collected from cannabis sales would be used to cover the program’s implementation costs as well as be utilized for public education and drug treatment to back community reinvestments and be diverted to schools via the state lottery fund.

The final law that was signed was a product of the negotiations between the state’s legislature and the governor. As early as January, the governor’s office had stated that the legalization of marijuana in the state would create more than 60,000 new employment opportunities, which would stimulate more than $3 billion in economic activity while bringing in about $300 million in tax revenue when the program had been fully implemented.

As New York and other states implement recreational marijuana programs, it will not be long before companies such as Hero Technologies Inc. (OTC: HENC), which favor the model of multi-state operators, come up to serve different markets across state borders.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Israeli-Made Medical Marijuana Inhaler Gets Nod from Canadian Authorities

Although several studies have proven that cannabis can treat conditions such as chronic pain, medical cannabis patients do not have a safe way to consume the plant. Save for taking the cannabis orally, most means of consumption such as smoking the flower and vaping come with a degree of risk. And since a large portion of medical cannabis patients are either older or they have compromised immune systems, any risk could be fatal.

Syqe Medical, a pharma-tech company based in Israel, has developed a proprietary medical cannabis delivery device that offers medical marijuana patients a much safer, more precise means of taking their medicine. The device, which has been dubbed the Syqe Inhaler, has been approved by Canadian Health officials and will soon be available to qualified Canadian patients. The Israeli company will sell the medical cannabis delivery device in partnership with a Canadian licensed producer via Syqe Medical Canada.

The technology behind the portable, handheld delivery device has been through a decade of extensive research and development, says Syqe Medical Canada’s General Manager Michael Molloy. This includes testing in a variety of research trials, and it resulted in the creation of a delivery device capable of releasing a controlled amount of cannabinoids in each inhalation. Not only will patients have a much safer way to take their medicine, but they will also be able to take precisely measured doses, a feat that has been pretty unachievable so far.

According to the medical director at Canada’s Centers for Pain Management, “unreliable dosing methods” such as smoking have hampered medical cannabis use. Consequently, physicians and patients alike have been looking for an alternative that would allow precise dosing each time, and the Syqe Inhaler fits this description perfectly. After raising more than $80 million in funding and spending close to a decade on research and development, the Tel Aviv-based firm came up with a metered-dose inhaler that met regulatory standards and is now eligible for distribution, at least in Canada.

Data from clinical trials done at Rambam Health Center located in Haifa, Israel, as well as data obtained from Israeli patients who had used the inhaler was instrumental in gaining Canada’s approval. The Canadian market has 370,000 registered medical cannabis patients and more than 5.8 million Canadian residents in total suffer from chronic pain. Projections put the market’s worth at around $380 million by 2024, and it will provide a major boost to Syqe’s business growth plan, the Israeli pharma-tech company said.

With lots of companies, such as Sonoma Biologics Corp., supplying high-grade medical cannabis in U.S. markets, it won’t be long before Syqe’s or other such devices are commercialized and made available to those who need them in all jurisdictions with legal medical marijuana programs.

NOTE TO INVESTORS: The latest news and updates relating to Sonoma Biologics Corp. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Texas House Approves Bill to Reduce Criminal Penalties for Cannabis Possession

Last week, the House in the state of Texas approved a measure that would decrease the criminal penalty for the possession of small amounts of cannabis, in addition to affording residents in the state who have been charged with cannabis possession the chance to expunge it from their records.

House Bill 441 applies to the possession of an ounce or less of cannabis.

Presently though, possessing up to two ounces of cannabis, which is equivalent to about 57 grams, is classified as a class B misdemeanor, which is punishable by a $2,000 fine and up to six months in jail.

The bill, which was drawn up by State Rep. Erin Zwiener, will re-classify the possession of an ounce or less of marijuana as a class C misdemeanor, whose punishment doesn’t include jail time. Additionally, law enforcement in the state will not be permitted to arrest individuals who are in possession of an ounce or less of marijuana.

During an interview with a nonprofit media outlet, Zwiener attributed much of the credit for reaching a compromise to State Rep. Joe Moody, who had suggested penalty reductions in the previous session. Zwiener added that while Gov. Abbott had made no commitment to sign the proposal if it reached his desk, she was encouraged by his comments, which supported the re-classification of punishments to a class C misdemeanor.

Zwiener observed that the real challenge would be getting the bill through the Senate. She explained that in 2019, after the House had approved a bill tabled by Moody, which was similar to this bill, Lt. Gov. Dan Patrick had opposed it, which led to its stalling.

Some law enforcement agencies and prosecutors in the state have already halted the arrest and prosecution of first offenders found in possession of small amounts of cannabis. A poll that was conducted earlier this year by the University of Texas discovered that 60% of voters in the state believe that the possession of any amount of cannabis should be legal.

House Bill 411 is an attempt to reduce the criminal penalty across the state for the possession of cannabis. Of the 10 measures tabled in the legislature to address possession, only a single other proposal has made it past the committee phase.

That bill, House Bill 09, was drawn up by Rep. Steve Toth and would eliminate the suspension of an individual’s driver’s license and their arrest for being in possession of cannabis, while also bringing the punishment down to a fine. Toth revealed that while he didn’t support the legalization or criminalization of cannabis, the racial disparity in cannabis arrests needed to be addressed.

As Texas moves to ease some of its strictest policies on marijuana, companies operating in the cannabis space, including XPhyto Therapeutics Inc. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), have advanced to the level of coming up with drug formulations from cannabis compounds. These compounds are in various stages of development, after which they may become widely available once the FDA gives its nod of approval.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — The Arguments For, Against Capping THC Concentration

Anyone who consumed cannabis in the ‘80s and ‘90s knows that these days, the compound is much stronger. The controversial plant is now allowed in several countries around the world with more than 40 states in America legalizing it in different ways. As the relatively young state-legal cannabis industry grows and matures, some have raised questions about marijuana’s increasing potency and the effects it may have on developing brains.

THC is the main cannabinoid responsible for cannabis’s intoxicating effects, and as cannabis companies develop more potent products, lawmakers across the country have started talking about potency caps. However, these lawmakers have faced plenty of pushback as the industry is now worth billions of dollars, with most projections predicting continuous growth. For instance, the executive director of Colorado’s Marijuana Industry Group Truman Bradley says potency limits are a “nonstarter,” although he does say that businesses in the cannabis space are open to conversation.

The human brain typically continues developing until a person turns 25, and studies have shown that chronic cannabis use can hamper this process. Potency caps are designed to keep highly potent products away from the hands of children and young adults. Colorado House Speaker Alec Garnett says high-potency products are becoming a problem and lawmakers need to tighten cannabis laws to protect young ones. Parents in Colorado are becoming increasingly worried about high THC products as well, with the left-leaning group Bule Rising Together adding THC potency caps on its agenda.

Additionally, chair and co-chair of the Senate Caucus on International Narcotics Control Senators John Cornyn and Dianne Feinstein issued a report that, among other things, argued for THC caps.

Still, cannabis industry advocates say potency caps are no different from the “reefer madness” of the yesteryears. Dodgy science coupled with irrational fears are the primary drivers behind the debate for THC potency caps, they argue, and cannabis should be treated like any other drug, including alcohol and tobacco. If lawmakers are successful in putting potency caps on marijuana products, advocates predict that people will simply turn to the black market to purchase the compound.

Mentioning the 2019 vaping crisis, which was largely caused by illegal and low-quality THC vaping products, National Cannabis Industry Association’s spokesperson Morgan Fox cautions against forcing customers to go underground for the highly potent cannabis products they’ve become accustomed to.

With more states opting to allow recreational cannabis, the debate surrounding the need for THC potency caps will rage on even stronger. Only time will tell which side comes out on top.

As that debate rages on, a number of companies that operate in the cannabis extracts space, including Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF), will continue to abide by any regulations that are set up to regulate the cannabis sector.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://cnw.fm/PULL

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Featured on BNN Bloomberg’s Market Call

Golden Leaf Holdings (CSE: GLH) (OTCQB: GLDFF), operating as Chalice Brands, a premier, consumer-driven cannabis company specializing in retail, production, processing, wholesale and distribution, was featured on Market Call, a weekday program broadcast by BNN Bloomberg where top fund managers and market analysts give their thoughts and top picks. Bruce Campbell, president at StoneCastle Investment Management, fielded questions from a caller in Windsor, Ontario, to give his thoughts on Golden Leaf Holdings. “They’ve had some sort of past issues in the fact that that market is very tough,” Campbell explained, addressing an unlimited number of licenses, a dropping price of cannabis and a previous management team that he indicates wasn’t very diligent in terms of spending. “The new management team that’s taken over are good operators,” Campbell said, explaining that, given a couple of good quarters showing progress in the right direction and cash generation, he believes the stock price will start to move.

To view the broadcast visit, https://cnw.fm/ZrPO5

About Golden Leaf Holdings Ltd.

Golden Leaf Holdings is a premiere consumer-driven cannabis company specializing in production, processing, wholesale, distribution and retail, with seven dispensaries in Portland, Oregon. The company is committed to developing a dynamic portfolio built around the recognized brands of Chalice Farms, with a focus on health and wellness. GLH operates nationally through Fifth and Root and has operations in Oregon and California. Visitwww.GLHMonthly.com for regular updates.

NOTE TO INVESTORS: The latest news and updates relating to GLDFF are available in the company’s newsroom at https://cnw.fm/GLDFF

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – VPR Brands LP (VPRB) Enforces IP Patent Rights, Files Lawsuits

VPR Brands (OTC: VPRB), a market leader and pioneer in electronic cigarettes and vaporizers for nicotine, cannabis and cannabidiol (“CBD”), has recently filed three lawsuits to protect it intellectual property (“IP”) rights. The company’s IP includes one of the original patents, dating back to 2009, filed for electronic cigarette technology. The patent covers claims associated with an electric airflow sensor that turns the battery on and off, as well as auto-draw, buttonless e-cigarettes, cigalikes, pod devices and vaporizers using an airflow sensor. The most recent lawsuits bring the total number of lawsuits the company has filed to nine; in the announcement, VPR Brands noted that it expects to file more as almost every company in the vape space offers at least one product using its patented auto-draw technology. The company and its legal counsel is in the process of identifying and notifying more than 50 companies about suspected infringement. “The surge of the vaping category for nicotine, cannabis and CBD in the last few years has reached billions of dollars in sales. That has created opportunities for our patented Auto-Draw technology, which we believe is now preferred by many, if not most consumers,” said VPR Brands CEO Kevin Frija in the press release. “Infringement can be avoided by simply adding a button to the battery. However, the preferred option by consumers to simulate smoking is our buttonless auto draw technology and we believe this is an opportune time to consider licensing, enforcement or potentially a sale of our intellectual property to one of the larger players in the space. Our Patent could be a huge windfall for the company.”

To view the full press release, visit https://cnw.fm/bUBVq

About VPR Brands LP

VPR Brands is a technology company, whose assets include issued U.S. and Chinese patents for atomization related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids, vaporizers and electronic cigarettes (also known as e-cigarettes) which are devices which deliver nicotine and or cannabis through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products. For more information, please visit www.VPRBrands.com.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.